Saroja Pharma Ind Financials

NSE: SAROJA

₹39.75

₹0.00 (0.00%)

As on 16-Sep-2026 10:07IST

Market cap

₹16 Cr

Revenue (TTM)

₹54 Cr

P/E Ratio

9.9

P/B Ratio

1

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Operating Revenue	53.73	40.67	50.19	55.63	36.66	--
Total Income	53.91	40.86	50.35	55.96	36.75	--
Total Expenditure	50.94	38.11	47.47	53.53	35.36	--
EBITDA	2.79	2.56	2.72	2.10	1.30	--
Depreciation	0.11	0.09	0.07	0.05	0.02	--
EBIT	2.67	2.46	2.65	2.06	1.28	--
Interest	1.41	1.45	1.32	0.80	0.33	--
Other Income	0.19	0.19	0.16	0.32	0.09	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	1.45	1.21	1.49	1.58	1.04	--
Provision for Tax	0.42	0.33	0.43	0.44	0.30	--
Profit after Tax	1.03	0.88	1.06	1.14	0.73	--

Liabilities (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Shareholder's Funds	15.68	14.64	5.09	4.03	0.94	--
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.39	2.63	2.82	1.70	1.42	--
Current Liabilities	22.49	9.29	13.43	9.79	5.87	--
Total Liabilities	39.55	26.56	21.34	15.51	8.22	--

Assets (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Non-Current Assets	12.34	8.96	5.19	0.42	0.12	--
Current Assets	27.22	17.60	16.15	15.09	8.10	--
Total Assets	39.55	26.56	21.34	15.51	8.22	--
Total Debt*	9.46	5.74	10.19	6.14	3.02	--
Net Current Assets	4.73	8.31	2.72	5.31	2.23	--
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Cash From Operating Activities	1.15	1.02	2.19	-3.67	-1.05	--
Cash Flow from Investing Activities	-2.70	-4.76	-4.82	-0.34	-0.05	--
Cash from Financing Activities	1.56	3.70	2.73	4.27	1.03	--
Net Cash Inflow / Outflow	0.01	-0.04	0.10	0.26	-0.07	--

Financials Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Adjusted EPS (₹)	2.57	2.18	3.61	3.88	56.25	--
Cash EPS (₹)	2.86	2.42	3.84	4.04	57.98	--
Adjusted Book Value (₹)	38.99	36.42	17.33	13.72	71.99	--
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	2.86	2.55	7.47	-162.71	-1,046.30	--
Free Cash Flow per Share (₹)	-0.83	-1.95	-9.70	-211.21	-1,430.70	--

Profitability Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
ROCE (%)	12.56	14.91	22.10	33.73	34.59	--
ROE (%)	6.82	8.90	23.28	45.95	78.14	--
ROA (%)	3.13	3.67	5.76	9.61	8.89	--
EBIT Margin (%)	4.98	6.06	5.29	3.70	3.50	--
Net Margin (%)	1.92	2.15	2.11	2.04	1.99	--
Cash Profit Margin (%)	2.14	2.39	2.25	2.13	2.06	--

Growth Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Revenue Growth (%)	32.11	-18.97	-9.78	51.75	--	--
EBIT Growth (%)	8.52	-7.14	28.98	60.42	--	--
Net Profit Growth (%)	17.75	-17.19	-6.97	55.90	--	--
EPS Growth (%)	17.75	-39.53	-6.98	-93.10	--	--
Book Value Growth (%)	7.06	187.84	26.34	330.17	--	--

Valuation Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Price / Earnings	14.68	16.07	--	--	--	--
Price / Book Value	0.97	0.96	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	8.17	7.10	4.43	2.51	2.18	--
Close Price (₹)	37.75	35.10	--	--	--	--
High Price (₹)	70.75	84.00	--	--	--	--
Low Price (₹)	33.10	35.00	--	--	--	--
Market Cap (₹ Cr)	15.18	14.11	--	--	--	--

Solvency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debt to Equity	0.60	0.39	2.00	1.52	3.22	--
Short term debt to equity ratio	0.52	0.21	1.45	1.10	1.71	--
Current Ratio	1.21	1.89	1.20	1.54	1.38	--
Quick Ratio	1.21	1.85	0.91	1.49	1.27	--
Interest Coverage	2.03	1.83	2.13	2.97	4.12	--

Operating Efficiency Ratios	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15
Debtors to sales (%)	49.47	39.93	22.13	25.13	19.70	--
Asset Turnover	1.63	1.70	2.72	4.69	4.46	--
Receivable days	145.45	122.72	91.22	69.56	71.92	--
Inventory Days	1.69	19.13	15.75	3.68	6.53	--
Payable days	74.63	61.58	45.99	35.58	47.31	--
Cash Conversion Cycle	72.51	80.28	60.98	37.66	31.14	--